PEGASO: Observational Study on Long-term Use of Pegunigalsidase Alfa in Fabry Patients in a Real-world Setting (clinicaltrials.gov) - Jul 9, 2026 - P=N/A | N=75 | Recruiting | Sponsor: Chiesi Italia | Not yet recruiting ➔ Recruiting
Enrollment open • Real-world evidence • Fabry Disease • Genetic Disorders
|